NCT01438476

Brief Summary

The goal of this clinical research study is to learn if there is a difference in patients' quality of recovery if they receive 1 of 2 standard kinds of pain control treatments after surgery on the liver and/or pancreas. Researchers want to learn which method helps people to recover more completely and more quickly after surgery. The 2 kinds of pain control are intravenous (IV) pain management and epidural pain management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
178

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2012

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 22, 2011

Completed
4 months until next milestone

Study Start

First participant enrolled

January 26, 2012

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2017

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

February 12, 2020

Completed
Last Updated

February 12, 2020

Status Verified

February 1, 2020

Enrollment Period

5.7 years

First QC Date

September 20, 2011

Results QC Date

January 23, 2020

Last Update Submit

February 4, 2020

Conditions

Keywords

Liver CancerPancreatic CancerThoracic epidural analgesiaTEAIntravenous patient-controlled analgesiaIVPCAPain controlQuality of lifeQOLSurgical resection

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pain Experience

    The Area Under the Curve (AUC) pain score during the first 48 hours after surgery. Post operative pain was measured during the first 48 hours per unit acuity guidelines. Typically this was at a minimum of every four hours yielding an average number of measures during the first 48 hours. The scale is 0-480 low scores are better.

    First 48 hours after surgery

Study Arms (2)

IV Pain Management

EXPERIMENTAL

Intravenous analgesia delivered prior to surgery, then patient-controlled following surgical procedures. Hourly post surgery rating level of pain on a scale of 0-10. Questions measure how quickly participant recovers from sedation Day 1 through Day 5 after surgery; approximately 20-40 minutes.

Procedure: Intravenous Patient-Controlled Analgesia (IVPCA)Behavioral: QuestionnairesBehavioral: Pain Assessment

Epidural Pain Management

EXPERIMENTAL

Thoracic epidurals placed preoperatively in either holding area or in operating room. Hourly post surgery rating level of pain on a scale of 0-10. Questions measure how quickly participant recovers from sedation Day 1 through Day 5 after surgery; approximately 20-40 minutes.

Procedure: Thoracic Epidural Analgesia (TEA)Behavioral: QuestionnairesBehavioral: Pain Assessment

Interventions

Intravenous analgesia delivered prior to surgery, then patient-controlled following surgical procedures.

IV Pain Management

Thoracic epidurals (needle inserted into the space between the covering of spinal cord and the cord itself) placed preoperatively in either the holding area or in the operating room.

Epidural Pain Management
QuestionnairesBEHAVIORAL

Questions measure how quickly participant recovers from sedation Day 1 through Day 5 after surgery; approximately 20-40 minutes.

Also known as: Survey
Epidural Pain ManagementIV Pain Management
Pain AssessmentBEHAVIORAL

Hourly post surgery rating level of pain on a scale of 0-10.

Epidural Pain ManagementIV Pain Management

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing liver and/or pancreatic surgical resection for malignancy at MD Anderson Cancer Center.
  • Patients 18 years of age and older. There will be no upper age restriction.
  • Patients must sign a study-specific consent form.
  • Adequate coagulation function within 30 days of surgery: Platelets \>/= 100,000/ml; international normalized ratio (INR) \</= 1.5; activated partial thromboplastin time (aPTT) \</= 40.
  • Patients must have no fever or evidence of infection or other coexisting medical condition that would preclude epidural placement.

You may not qualify if:

  • Evidence of severe uncontrolled systemic disease or other comorbidity that precludes liver or pancreatic surgery.
  • History of chronic pain, long-term narcotic use or being considered for chronic pain consultation postoperatively.
  • Anaphylaxis to local anesthetics or narcotics.
  • Previous or current neurologic disease affecting the lower hemithorax or below.
  • Major open abdominal/thoracic surgery in the previous 30 days under general anesthesia, except for total intravenous anesthesia (TIVA).
  • Technical contraindications to epidural placement: previous thoracic spinal surgery or local skin or soft tissue infection at proposed site for epidural insertion.
  • Ongoing use or planned peri-operative use of anticoagulants (not including deep vein thrombosis (DVT) prophylaxis).
  • Known bleeding diathesis or coagulopathy.
  • Educational, psychiatric (untreated or poorly controlled schizophrenia, major depression, or bipolar disorder), or communication (language) barrier that would preclude accurate assessment of postoperative pain and/or ability to answer questionnaires (need to be able to read, comprehend, and answer questions).
  • Inability to comply with study and/or follow-up procedures.
  • Patient refusal to participate in randomization.
  • Pregnant women are excluded from this study; women of childbearing potential (defined as those who have not undergone a hysterectomy or who have not been postmenopausal for at least 12 consecutive months) must agree to practice adequate contraception and to refrain from breast-feeding, as specified in the informed consent.
  • Patients with obvious unresectable disease prior to signing informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Publications (2)

  • Cata JP, Velasquez JF, Ramirez MF, Vauthey JN, Gottumukkala V, Conrad C, Kim BJ, Aloia T. Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol. 2017 Aug 10;15(1):152. doi: 10.1186/s12957-017-1220-6.

  • Aloia TA, Kim BJ, Segraves-Chun YS, Cata JP, Truty MJ, Shi Q, Holmes A, Soliz JM, Popat KU, Rahlfs TF, Lee JE, Wang XS, Morris JS, Gottumukkala VNR, Vauthey JN. A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia After Major Hepatopancreatobiliary Surgery. Ann Surg. 2017 Sep;266(3):545-554. doi: 10.1097/SLA.0000000000002386.

Related Links

MeSH Terms

Conditions

Liver NeoplasmsPancreatic NeoplasmsAgnosia

Interventions

Analgesia, Patient-ControlledTeaSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesLiver DiseasesEndocrine Gland NeoplasmsPancreatic DiseasesEndocrine System DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnalgesiaAnesthesia and AnalgesiaPlant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Results Point of Contact

Title
Dr. Jean-Nicolas Vauthey,MD/Professor, Surgical Oncology
Organization
UT MD Anderson Cancer Center

Study Officials

  • Jean-Nicolas Vauthey, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2011

First Posted

September 22, 2011

Study Start

January 26, 2012

Primary Completion

October 18, 2017

Study Completion

October 18, 2017

Last Updated

February 12, 2020

Results First Posted

February 12, 2020

Record last verified: 2020-02

Locations